Complete List of Janus kinase (JAK) inhibitor Medicines
Brand: CIBINQO |
Strength: 100 mg |
Form: Film Coated Tablets
Class: | Janus kinase (JAK) inhibitor
Use: | Treatment of moderate to severe atopic dermatitis in adults and pediatric patients 12 years and older
Adult dose: | 100 mg once daily; may be adjusted ...
Brand: CIBINQO |
Strength: 200 mg |
Form: Tablets
Class: | Janus kinase (JAK) inhibitor
Use: | Treatment of moderate to severe atopic dermatitis in adults and pediatric patients 12 years and older who are candidates for systemic therapy
Adult dos...
Brand: CIBINQO |
Strength: 200 mg/1 Tablet |
Form: Film Coated Tablets
Class: | Janus kinase (JAK) inhibitor
Use: | Treatment of moderate to severe atopic dermatitis in adults and pediatric patients 12 years and older who are candidates for systemic therapy
Adult dos...
Brand: CIBINQO |
Strength: 50 mg |
Form: Film Coated Tablets
Class: | Janus kinase (JAK) inhibitor
Use: | Treatment of moderate to severe atopic dermatitis in adults and pediatric patients 12 years and older who are candidates for systemic therapy
Adult dos...
Brand: OLUMIANT |
Strength: 2 mg |
Form: Tablets
Class: | Janus kinase (JAK) inhibitor
Use: | Treatment of moderate to severe rheumatoid arthritis in adults who have had an inadequate response to one or more tumor necrosis factor (TNF) inhibitors;...
Brand: OLUMIANT |
Strength: 4 mg |
Form: Tablets
Class: | Janus kinase (JAK) inhibitor
Use: | Treatment of moderate to severe rheumatoid arthritis in adults who have had an inadequate response to one or more TNF inhibitors; also approved for the t...
Brand: Anzupgo |
Strength: 20 mg/1g |
Form: Cream
Class: | Topical Janus kinase (JAK) inhibitor
Use: | Treatment of moderate to severe atopic dermatitis in adults and pediatric patients aged 12 years and older
Adult dose: | Apply a thin layer to ...
Brand: SOTYKTU |
Strength: 6 mg |
Form: Film Coated Tablets
Class: | Janus kinase (JAK) inhibitor
Use: | Treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy
Adult dose: | 6 mg orally once daily...
Brand: OMJJARA |
Strength: 100 mg |
Form: Tablets
Class: | Janus kinase (JAK) inhibitor
Use: | Treatment of myelofibrosis in adults, particularly in patients with anemia
Adult dose: | 100 mg orally once daily
Pediatric dose: | Safety and effica...
Brand: OMJJARA |
Strength: 100 mg |
Form: Tablets
Class: | Janus kinase (JAK) inhibitor
Use: | Treatment of myelofibrosis in adults, particularly in patients with anemia
Adult dose: | 100 mg orally once daily
Pediatric dose: | Safety and effica...
Brand: OMJJARA |
Strength: 150 mg |
Form: Tablets
Class: | Janus kinase (JAK) inhibitor
Use: | Treatment of myelofibrosis in adults, particularly in patients with anemia
Adult dose: | 150 mg orally once daily
Pediatric dose: | Safety and effica...
Brand: OMJJARA |
Strength: 200 mg |
Form: Tablets
Class: | Janus kinase (JAK) inhibitor
Use: | Treatment of myelofibrosis in adults, particularly in patients with anemia
Adult dose: | 200 mg orally once daily
Pediatric dose: | Safety and effica...
Brand: VONJO |
Strength: 100 mg |
Form: Capsules
Class: | Janus kinase (JAK) inhibitor
Use: | Treatment of adult patients with intermediate or high-risk primary or secondary myelofibrosis
Adult dose: | 100 mg orally once daily
Pediatric dose: ...
Brand: Litfulo |
Strength: 50 mg |
Form: Capsules
Class: | Janus kinase (JAK) inhibitor
Use: | Treatment of moderate to severe alopecia areata in adults and pediatric patients aged 12 years and older
Adult dose: | 50 mg orally once daily
Pediat...
Brand: JAKAVI |
Strength: 15 mg |
Form: Tablets
Class: | Janus kinase (JAK) inhibitor
Use: | Treatment of intermediate or high-risk myelofibrosis, polycythemia vera in patients who have had an inadequate response to or are intolerant of hydroxyur...
Brand: JAKAVI |
Strength: 20 mg |
Form: Tablets
Class: | Janus kinase (JAK) inhibitor
Use: | Treatment of intermediate or high-risk myelofibrosis, polycythemia vera in patients resistant to or intolerant of hydroxyurea, and graft-versus-host dise...
Brand: JAKAVI |
Strength: 5 mg |
Form: Tablets
Class: | Janus kinase (JAK) inhibitor
Use: | Treatment of intermediate or high-risk myelofibrosis, polycythemia vera in patients with an inadequate response to hydroxyurea, and graft-versus-host dis...
Brand: OPZELURA |
Strength: 1.5 % |
Form: Cream
Class: | Janus kinase (JAK) inhibitor
Use: | Treatment of mild to moderate atopic dermatitis in adults and pediatric patients aged 12 years and older
Adult dose: | Apply a thin layer to the affect...
Brand: OPZELURA |
Strength: 1.5 % |
Form: Cream
Class: | Janus kinase (JAK) inhibitor
Use: | Treatment of mild to moderate atopic dermatitis in adults and pediatric patients aged 12 years and older
Adult dose: | Apply a thin layer of Ruxolitini...
Brand: XELJANZ |
Strength: 5 mg |
Form: Tablets
Class: | Janus kinase (JAK) inhibitor
Use: | Treatment of moderate to severe rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis in adults; also approved for atopic dermatitis in certa...
Brand: XELJANZ |
Strength: 10 mg |
Form: Tablets
Class: Janus kinase (JAK) inhibitor
Use: Treatment of rheumatoid arthritis, psoriatic arthritis, ulcerative colitis
Adult dose: 10 mg twice daily for ulcerative colitis (initially), then reduce to...
Brand: XELJANZ |
Strength: 11 mg |
Form: Extended Release Tablets
Class: | Janus kinase (JAK) inhibitor
Use: | Treatment of moderate to severe rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis in adults; also indicated for atopic dermatitis in cert...
Brand: RINVOQ |
Strength: 15 mg |
Form: Prolonged Release Tablets
Class: | Janus kinase (JAK) inhibitor
Use: | Upadacitinib is indicated for the treatment of moderate to severe rheumatoid arthritis, active psoriatic arthritis, ankylosing spondylitis, and moderate t...
Brand: RINVOQ |
Strength: 30 mg |
Form: Prolonged Release Tablets
Class: | Janus kinase (JAK) inhibitor
Use: | Treatment of moderate to severe rheumatoid arthritis in adults, atopic dermatitis in adults and pediatric patients 12 years and older, and ulcerative col...
Brand: RINVOQ |
Strength: 45 mg |
Form: Prolonged Release Tablets
Class: | Janus kinase (JAK) inhibitor
Use: | Treatment of moderate to severe rheumatoid arthritis in adults, atopic dermatitis, and ulcerative colitis
Adult dose: | 45 mg once daily for rheumatoid...
Brand: RINVOQ 15mg |
Strength: 15 mg |
Form: Prolonged Release Tablets
Class: | Janus kinase (JAK) inhibitor
Use: | Treatment of moderate to severe rheumatoid arthritis in adults, atopic dermatitis in adults and pediatric patients 12 years and older, and ulcerative col...